|
Chronic Conditions Management |
 |
 |
 |
 |
The objective
The programme’s principal objective is to provide a workable, scalable model for the holistic management of chronic conditions for EU citizens, taking into account the medical, socio-economic and technology dimensions.
The model will be based on a benchmark of best practices across Europe with the aim of establishing a European standard that can be used by EU Member States in their non-disease specific national plans for the management of chronic conditions. It will focus on the commonalities across conditions but use some specific disease areas as case studies to illustrate particular aspects of the model.
To find out more about the programme, contact: Dr Andrea Pavlickova, AIP-CCM Researcher.
To become a programme member, contact:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
, Executive Director.
|
|
|
Programme Participants
Observer members
European Commission DG Information Society & Media
European Commission – DG Health and Consumers (Sanco)
European Parliament
OSHA – European Agency for Safety and Health at Work
| Patient Organisations |
Science, Academia & Public Administrations |
Industry and Payer Community |
| CF Europe (Cystic Fibrosis) |
Belgian Federal Ministry of Health |
Abbott |
| EFA - European Federation of Asthma and Allergy Associations |
Cancer Research UK |
AIM - Association Internationale de la Mutualité |
| EFCCA - European Federation of Crohn's and Colitis Associations |
Delft University of Technology |
Amgen |
| EFNA - European Federation of Neurological Associations |
EFMI – European Federation for Medical Informatics |
EDMA - European Diagnostic Manufacturers Association |
| EGAN - European Genetic Alliances’ Network |
Fit for Work Europe
|
EFPIA - European Federation of Pharmaceutical Industries and Associations |
| European Multiple Sclerosis Platform |
RAPS - Regulatory Affairs Profesionals Society |
Eucomed - medical technology industry in Europe |
| EPDA - European Parkinson's Disease Association |
SIP - Societal Impact of Pain |
GSK |
|
EuropaUomo - Prostate Cancer Coalition
|
University of Cologne |
Johnson & Johnson |
| EURORDIS - Rare Diseases Europe |
|
Medtronic |
| GAMIAN-Europe - Global Alliance of Mental Illness Advocacy Networks - Europe |
|
Merck Serono |
| InterChol - International Cholesterol Foundation |
|
MSD |
|
Retina Europe
|
|
Novartis |
| WFIP - World Federation of Incontinent Patients |
|
Novo Nordisk |
|
|
Pfizer |
|
|
Roche |
|
Chronic Conditions Management
